Luigia Monitillo

1.2k total citations
16 papers, 497 citations indexed

About

Luigia Monitillo is a scholar working on Pathology and Forensic Medicine, Genetics and Cancer Research. According to data from OpenAlex, Luigia Monitillo has authored 16 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 6 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Luigia Monitillo's work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Genomics and Diagnostics (5 papers). Luigia Monitillo is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Genomics and Diagnostics (5 papers). Luigia Monitillo collaborates with scholars based in Italy, Germany and Slovakia. Luigia Monitillo's co-authors include Marco Ladetto, Simone Ferrero, Mario Boccadoro, Daniela Drandi, Malek Faham, Christiane Pott, Heiko Trautmann, Roberto Passera, Monika Brüggemann and Jianbiao Zheng and has published in prestigious journals such as Blood, Gut and BMC Bioinformatics.

In The Last Decade

Luigia Monitillo

15 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luigia Monitillo Italy 8 151 145 134 121 112 16 497
H J Gruss Germany 11 165 1.1× 130 0.9× 117 0.9× 99 0.8× 101 0.9× 13 559
Andrei Cucuianu Romania 11 114 0.8× 39 0.3× 284 2.1× 82 0.7× 119 1.1× 32 509
Honghui Huang China 14 76 0.5× 114 0.8× 183 1.4× 123 1.0× 23 0.2× 37 471
Markus Müschen United States 13 171 1.1× 56 0.4× 400 3.0× 195 1.6× 72 0.6× 20 884
Gabriele Margareta Siegler Germany 14 214 1.4× 50 0.3× 286 2.1× 176 1.5× 57 0.5× 35 641
Plamen Kossev United States 9 122 0.8× 165 1.1× 185 1.4× 238 2.0× 101 0.9× 13 611
José María Fernández‐Rañada Spain 10 136 0.9× 93 0.6× 101 0.8× 127 1.0× 134 1.2× 16 349
María Laura Gutiérrez Spain 15 54 0.4× 182 1.3× 145 1.1× 195 1.6× 96 0.9× 30 496
Marjan Daneshpouy France 9 142 0.9× 172 1.2× 100 0.7× 117 1.0× 54 0.5× 12 505
Thérèse Aurran‐Schleinitz France 12 85 0.6× 152 1.0× 61 0.5× 109 0.9× 178 1.6× 26 397

Countries citing papers authored by Luigia Monitillo

Since Specialization
Citations

This map shows the geographic impact of Luigia Monitillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigia Monitillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigia Monitillo more than expected).

Fields of papers citing papers by Luigia Monitillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigia Monitillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigia Monitillo. The network helps show where Luigia Monitillo may publish in the future.

Co-authorship network of co-authors of Luigia Monitillo

This figure shows the co-authorship network connecting the top 25 collaborators of Luigia Monitillo. A scholar is included among the top collaborators of Luigia Monitillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigia Monitillo. Luigia Monitillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ferrero, Simone, Davide Rossi, Alessio Bruscaggin, et al.. (2017). KMT2D AND TP53 MUTATIONS PREDICT POOR PFS AND OS IN MANTLE CELL LYMPHOMA RECEIVING HIGH‐DOSE THERAPY AND ASCT: THE FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 PHASE III TRIAL. Hematological Oncology. 35(S2). 94–95. 2 indexed citations
2.
Ferrero, Simone, Elisa Genuardi, Petra Klous, et al.. (2017). NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE (MRD) MONITORING IN MANTLE CELL AND FOLLICULAR LYMPHOMA: THE TARGETED LOCUS AMPLIFICATION (TLA) NGS STRATEGY. Hematological Oncology. 35(S2). 151–151. 1 indexed citations
3.
Beccuti, Marco, Elisa Genuardi, Luigia Monitillo, et al.. (2017). HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data. BMC Bioinformatics. 18(1). 516–516. 7 indexed citations
5.
Mannu, Claudia, Anna Gazzola, Elena Ciabatti, et al.. (2014). Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease Network. Leukemia & lymphoma. 57(2). 400–410. 3 indexed citations
6.
Bruno, Benedetto, Simone Ferrero, Daniela Drandi, et al.. (2014). Prospective Molecular Monitoring of Minimal Residual Disease after Non-Myeloablative Allografting in Newly Diagnosed Multiple Myeloma. Blood. 124(21). 44–44. 1 indexed citations
7.
Ferrero, Simone, Luigia Monitillo, Barbara Mantoan, et al.. (2013). Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. Annals of Hematology. 92(11). 1503–1511. 10 indexed citations
8.
Ladetto, Marco, Monika Brüggemann, Luigia Monitillo, et al.. (2013). Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. Leukemia. 28(6). 1299–1307. 218 indexed citations
9.
Pott, Christiane, Luigia Monitillo, Elisa Genuardi, et al.. (2013). A Comparative Analysis Of Next-Generation Sequencing and Real-Time Quantitative PCR For Minimal Residual Disease Detection In Follicular Lymphomas. Blood. 122(21). 4293–4293. 4 indexed citations
10.
Lobetti‐Bodoni, Chiara, Barbara Mantoan, Luigia Monitillo, et al.. (2013). Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma. Therapeutic Advances in Hematology. 4(3). 189–198. 10 indexed citations
13.
Ladetto, Marco, Simone Ferrero, Daniela Drandi, et al.. (2012). High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma. Blood. 120(21). 4204–4204.
14.
Lamorte, Sara, Simone Ferrero, Simona Aschero, et al.. (2011). Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells. Leukemia. 26(5). 1081–1090. 58 indexed citations
15.
Ricca, Irene, Alberto Rocci, Daniela Drandi, et al.. (2007). Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients. Leukemia. 21(4). 697–705. 33 indexed citations
16.
Novo, Erica, Fabio Marra, E. Zamara, et al.. (2006). Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut. 55(8). 1174–1182. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026